Back to Search
JANET PRIBBLE, M.D.
M.D.
Emergency Medicine Physician
NPI: 1215995931Individual
Specialties, Licenses & Credentials
Emergency Medicine PhysicianPrimary
Emergency Medicine
Code: 207P00000X
01052895A(IN)15267(AL)
Research & Publications (19)
Injury reporting on local TV news: a prime-time opportunity for prevention.
PMID 18407009·Am J Prev Med·2008
8-other
Stroke information reported on local television news: a national perspective.
PMID 16675736·Stroke·2006
8-other
Parental perceptions regarding mandatory mouthguard use in competitive youth soccer.
PMID 15178672·Inj Prev·2004
8-other
Evaluation of recombinant platelet-activating factor acetylhydrolase for reducing the incidence and severity of post-ERCP acute pancreatitis.
PMID 19231487·Gastrointest Endosc·2009
3-trial
Longitudinal studies of inter-alpha inhibitor proteins in severely septic patients: a potential clinical marker and mediator of severe sepsis.
PMID 17205024·Crit Care Med·2007
8-other
National Highway Traffic Safety Administration (NHTSA) notes. A social norms strategy to reduce impaired driving among 21- to 34-year-olds.
PMID 17120326·Ann Emerg Med·2006
8-other
Medical news for the public to use? What's on local TV news.
PMID 16524349·Am J Manag Care·2006
8-other
Plasma cytokine measurements augment prognostic scores as indicators of outcome in patients with severe sepsis.
PMID 15897799·Shock·2005
3-trial
CD14 receptor occupancy in severe sepsis: results of a phase I clinical trial with a recombinant chimeric CD14 monoclonal antibody (IC14).
PMID 15190957·Crit Care Med·2004
3-trial
Recombinant human platelet-activating factor acetylhydrolase for treatment of severe sepsis: results of a phase III, multicenter, randomized, double-blind, placebo-controlled, clinical trial.
PMID 14758145·Crit Care Med·2004
3-trial
An overview of clinical studies in healthy subjects and patients with severe sepsis with IC14, a CD14-specific chimeric monoclonal antibody.
PMID 14733726·J Endotoxin Res·2003
6-review
Molecular characterization of the acute inflammatory response to infections with gram-negative versus gram-positive bacteria.
PMID 14500502·Infect Immun·2003
4-observational
Recombinant platelet-activating factor acetylhydrolase to prevent acute respiratory distress syndrome and mortality in severe sepsis: Phase IIb, multicenter, randomized, placebo-controlled, clinical trial.
PMID 12794395·Crit Care Med·2003
3-trial
Treatment with an anti-CD14 monoclonal antibody delays and inhibits lipopolysaccharide-induced gene expression in humans in vivo.
PMID 12757265·J Clin Immunol·2003
8-other
Effects of IC14, an anti-CD14 antibody, on coagulation and fibrinolysis during low-grade endotoxemia in humans.
PMID 12508146·J Infect Dis·2003
3-trial
IC14, a CD14 specific monoclonal antibody, is a potential treatment for patients with severe sepsis.
PMID 11717588·J Endotoxin Res·2001
6-review
IC14, an anti-CD14 antibody, inhibits endotoxin-mediated symptoms and inflammatory responses in humans.
PMID 11207321·J Immunol·2001
3-trial
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 1530 US HIGHWAY 43
WINFIELD, AL 35594 - Phone
- (205) 979-7593
Quick Facts
- NPI
- 1215995931
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Not confirmed
- Specialties
- 2
- Locations
- 1
- Publications
- 19
Are you this provider?
Claim Your Profile